comparemela.com

Latest Breaking News On - Anvil wealth management - Page 1 : comparemela.com

Anvil PMS to shut shop amid regulatory glare - The Hindu BusinessLine

Anvil PMS to shut shop amid regulatory glare - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Front Running Case: SEBI Bans 6 Entities, Impounds Gains Of Rs 2.2 Crore

Capital markets regulator Sebi (Securities and Exchange Board of India) has restrained six entities, including Banhem Stock Broking and Ninja Securities, from the securities market and impounded wrongful gains of Rs 2.23 crore from them for involving in front running trades of Anvil Wealth Management.

From Sageone to Anvil Wealth, most PMS schemes beat Nifty in April

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription. In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product.

pms funds: Largecap-focussed PMSes lagged in April; midcap specialists fared better

Explore Now NEW DELHI: Smallcap- and multicap-oriented PMS (portfolio management service) funds, an investment tool of rich investors, outperformed in April and delivered up to 14 per cent returns to clients. Top guns of the PMS industry also delivered handsome returns for the month. Domestic equity benchmark Sensex fell 1.5 per cent for the month, while Nifty shed 0.4 per cent. Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent, according to data provided by PMSBazaar. Sun Pharma, Dr Reddy’s Labs, Cipla, Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio. Sectoral bets, especially metals, pharma and IT, have been proving to be beneficial for fund managers in the past couple of months, as the Covid-19 pandemic intensified and commodity prices rose.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.